Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
966.5 USD | +0.02% | -0.07% | +10.02% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 25 | Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment | MT |
- Stock
- Equities
- Stock Regeneron Pharmaceuticals, Inc. - Nasdaq
- News Regeneron Pharmaceuticals, Inc.